ArticlePilot and feasibility studies2023

Acceptability and readiness to promote human papillomavirus vaccination at ages 9-10 years: a feasibility study among North Carolina clinics.

Nadja A Vielot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.